Skip to content
Home/Companies/Biotech/Asceneuron
AS

Asceneuron

Biotech·Switzerland·Active·6yr hold

Asceneuron is a healthcare company, headquartered in France.

Entry
2020
Hold
6yr
Status
Active
Est. EV
–

Who owns Asceneuron?

Asceneuron is currently owned by Sofinnova Partners through Sofinnova Capital IX (2018 vintage), since 2020. Across its history, Asceneuron has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Sofinnova Partners
Most recent investor
Sofinnova Partners
Sofinnova Capital IX · 2018 · Life Sciences VC
2 ownership periods · full history below

Key facts

HQFrance
SectorHealthcare

Ownership history

2 ownership periods · co-invest detected

Active
Currently held by Sofinnova Partners since 2020.
Co-invest · 2 holders · 2020 · present
Kurma Partners
Kurma PartnersExited
2020 · Kurma Biofund II · 2013 · VC
MOIC
–
Sofinnova Partners
Sofinnova PartnersActive
2020 · present · Sofinnova Capital IX · 2018 · Life Sciences VC
MOIC
–

More from Sofinnova Capital IX

Other portfolio companies in the same fund.

CorVent Medical
Active
MedTechUS· 2020
Genespire
Active
BiotechItaly· 2020
Nitrase Therapeutics
Active
BiotechUS· 2020
Noema Pharma
Exited 2022
BiotechSwitzerland· 2020
to
Pi-Cardia
Active
MedTechIsrael· 2020
Pyrowave
Active
BiotechCanada· 2020

More PE-backed in Biotech

Comparable biotech deals from other GPs.

InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Data refreshed weekly · Sourced from public filings